Alterity Therapeutics Lim... (ATHE)
NASDAQ: ATHE
· Real-Time Price · USD
4.21
0.02 (0.48%)
At close: Oct 03, 2025, 3:59 PM
4.24
0.83%
After-hours: Oct 03, 2025, 04:10 PM EDT
Alterity Therapeutics Income Statement
Financials in AUD. Fiscal
year is
July - June.
| Fiscal Year | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Jun 30, 2025 | Dec 31, 2024 | Jun 30, 2024 | Dec 31, 2023 | Jun 30, 2023 | Dec 31, 2022 | Jun 30, 2022 | Dec 31, 2021 | Jun 30, 2021 | Dec 31, 2020 |
Revenue | 5.44M | 3.72M | 4.02M | 3.43M | 3.92M | 5.15M | 5.12M | 4.82M | 4.34M | 28.15K |
Cost of Revenue | 127.52K | 137.21K | 147.53K | 126.18K | 102.26K | 72.67K | 54.21K | 71.27K | 75.37K | 286.32K |
Gross Profit | 5.31M | 3.59M | 3.87M | 3.31M | 3.81M | 5.08M | 5.07M | 4.74M | 4.26M | -258.17K |
Operating Income | -14.57M | -20.47M | -17.48M | -12.27M | -18.52M | -21.21M | -20.62M | -20.04M | -19.52M | -17.78M |
Interest Income | n/a | 150.02K | 268.42K | 123.46K | 16.44K | 12.53K | 2.5K | 15.47K | 20.68K | 9.54K |
Pretax Income | -13.69M | -21.35M | -16.96M | -11.69M | -17.62M | -19.04M | -17.45M | -17.71M | -19.44M | -18.26M |
Net Income | -12.15M | -19.79M | -19.12M | -12.28M | -13.81M | -14.3M | -12.85M | -13.33M | -15.31M | -16.38M |
Selling & General & Admin | 5.48M | 5.99M | 4.76M | 4.37M | 5.22M | 5.39M | 5.82M | 6.73M | 7.16M | 5.48M |
Research & Development | 14.4M | 18M | 18.64M | 11.8M | 13.2M | 15.75M | 14.75M | 13.24M | 12.28M | 10.16M |
Other Expenses | n/a | 23.05K | 23.05K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 19.89M | 24.01M | 23.43M | 16.17M | 18.42M | 21.14M | 20.57M | 19.97M | 19.44M | 15.64M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | 308.14K | -9.67K | 25.49K | 25.74K | 43.07K | 39.66K | -7.2K | 10.91K | 63.76K |
Cost & Expenses | 20.01M | 24.19M | 23.62M | 16.29M | 18.52M | 21.21M | 20.62M | 20.04M | 19.52M | 15.93M |
Income Tax Expense | -1.54M | -3.68M | -3.97M | -3.43M | -3.81M | -4.75M | -4.6M | -4.38M | -4.13M | -1.88M |
Shares Outstanding (Basic) | 12.47M | 8.54M | 10.51M | 4.17M | 4.07M | 4.02M | 4.01M | 4.01M | 3.47M | 2.21M |
Shares Outstanding (Diluted) | 12.47M | 8.86M | 10.51M | 4.17M | 4.07M | 4.02M | 4.01M | 4.01M | 3.47M | 2.21M |
EPS (Basic) | -1.26 | -2.04 | -2.76 | -3 | -3.42 | -3.54 | -3.18 | -3.54 | -5.82 | -9 |
EPS (Diluted) | -1.26 | -2.04 | -2.76 | -3 | -3.42 | -3.54 | -3.18 | -3.54 | -5.82 | -9 |
EBITDA | -14.63M | -22.14M | -22.95M | -15.58M | -17.51M | -18.97M | -17.39M | -17.64M | -19.36M | -18.55M |
EBIT | -14.66M | -22.23M | -23.1M | -15.71M | -17.62M | -19.04M | -17.45M | -17.71M | -19.44M | -18.59M |
Depreciation & Amortization | 28.31K | 90.47K | 147.53K | 126.18K | 102.26K | 72.67K | 54.21K | 71.27K | 75.37K | 47.23K |